Yongxin Zhang

Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

hPSC-derived sacral neural crest cells restore erectile function in pelvic ganglia injury.

hPSC-derived sacral neural crest cells restore erectile function in pelvic ganglia injury.

Journal: Stem cell research & therapy

Published: June 13, 2025

YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer.

YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer.

Journal: Signal transduction and targeted therapy

Published: March 20, 2025

Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY +CD8+ T cells.

Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY +CD8+ T cells.

Journal: Gut

Published: March 11, 2025

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.

Journal: Cancer cell

Published: March 11, 2025

Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal Metastasis.

Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal Metastasis.

Journal: ImmunoTargets and therapy

Published: November 19, 2024

Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression.

Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression.

Journal: Cancer cell

Published: October 10, 2024

ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling.

ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling.

Journal: Cancer letters

Published: January 09, 2024

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.

Journal: Cancer cell

Published: December 14, 2023

CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p/PGK1 pathway and inhibiting vimentin phosphorylation.

CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p/PGK1 pathway and inhibiting vimentin phosphorylation.

Journal: Journal of translational medicine

Published: August 19, 2023

RP11-789C1.1 inhibits gastric cancer cell proliferation and accelerates apoptosis via the ATR/CHK1 signaling pathway.

RP11-789C1.1 inhibits gastric cancer cell proliferation and accelerates apoptosis via the ATR/CHK1 signaling pathway.

Journal: Chinese medical journal

Published: November 20, 2022

Integrated analysis of the functions and clinical implications of exosome circRNAs in colorectal cancer.

Integrated analysis of the functions and clinical implications of exosome circRNAs in colorectal cancer.

Journal: Frontiers in immunology

Published: April 13, 2022

A Diagnostic Model Using Exosomal Genes for Colorectal Cancer.

A Diagnostic Model Using Exosomal Genes for Colorectal Cancer.

Journal: Frontiers in genetics

Published: January 27, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026